Anterior chamber paracentesis after central retinal artery occlusion: A tenable therapy?

BMC Ophthalmology

Volumn 14, Issue 1, 2014, Pages

  Fieß, Achim ^a   Cal, Ömer ^a   Kehrein, Stephan ^a   Halstenberg, Sven ^a   Frisch, Inez ^b   Steinhorst, Ulrich Helmut ^b  

^a Department of Dermatology and Allergology   (Germany)

^b Center of Ophthalmology   (Germany)

Author keywords

Central retinal artery occlusion; Intraocular pressure; Paracentesis; Retinal vascular occlusion; Treatment

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; AGED; ANTERIOR EYE CHAMBER; ARTICLE; FEMALE; GERMANY; HUMAN; INTRAOCULAR PRESSURE; MALE; METHODOLOGY; MIDDLE AGED; PARACENTESIS; PATHOPHYSIOLOGY; RETINA ARTERY OCCLUSION; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; VISUAL ACUITY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTERIOR CHAMBER; ANTICOAGULANTS; FEMALE; GERMANY; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PARACENTESIS; RETINAL ARTERY OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL ACUITY;

EID: 84899064155     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-14-28     Document Type: Article

References (29)

1. Management of acute central retinal artery occlusion. Chen CS, Lee AW, Nat Clin Pract Neurol 2008 4 7 376 383 18542123
2. Aggressive systematic treatment for central retinal artery occlusion. Rumelt S, Dorenboim Y, Rehany U, Am J Ophthalmol 1999 128 6 733 738 10.1016/S0002-9394(99)00359-1 10612510
3. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Schumacher M, Schmidt D, Jurklies B, Gall C, Wanke I, Schmoor C, Maier-Lenz H, Solymosi L, Brueckmann H, Neubauer AS, Wolf A, Feltgen N, EAGLE-Study Group, Ophthalmology 2010 117 7 1367 1375 e1361 10.1016/j.ophtha.2010.03.061 20609991
4. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H, Am J Ophthalmol 2008 146 5 700 706 10.1016/j.ajo.2008. 06.016 18718570
5. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Kattah JC, Wang DZ, Reddy C, Arch Ophthalmol 2002 120 9 1234 1236 10.1001/archopht.120.9.1234
6. Visual prognosis following treatment of acute central retinal artery obstruction. Augsburger JJ, Magargal LE, Br J Ophthalmol 1980 64 12 913 917 10.1136/bjo.64.12.913 7448144
7. A rationalization of treatment of central retinal artery occlusion. Ffytche TJ, Trans Ophthalmol Soc U K 1974 94 2 468 479 4619853
8. The effect of acetazolamide on the retinal circulation. Rassam SM, Patel V, Kohner EM, Eye (Lond) 1993 7 Pt 5 697 702 8287997
9. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Atebara NH, Brown GC, Cater J, Ophthalmology 1995 102 12 2029 2034 discussion 2034-2025 10.1016/S0161-6420(95) 30758-0 9098313
10. Central retinal artery occlusion and retinal tolerance time. Hayreh SS, Kolder HE, Weingeist TA, Ophthalmology 1980 87 1 75 78 10.1016/S0161-6420(80) 35283-4 6769079
11. Experimental occlusion of the central artery of the retina. IV: Retinal tolerance time to acute ischaemia. Hayreh SS, Weingeist TA, Br J Ophthalmol 1980 64 11 818 825 10.1136/bjo.64.11.818 7426553
12. Experimental occlusion of the central artery of the retina. I. Ophthalmoscopic and fluorescein fundus angiographic studies. Hayreh SS, Weingeist TA, Br J Ophthalmol 1980 64 12 896 912 10.1136/bjo.64.12.896 7448143
13. Central retinal artery obstruction and visual acuity. Brown GC, Magargal LE, Ophthalmology 1982 89 1 14 19 10.1016/S0161-6420(82)34853-8 7070767
14. Retinal arterial occlusion. Gold D, Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977 83 3 Pt 1 P392 OP408 329528
15. Clinical characteristics and outcome of current standard management of central retinal artery occlusion. Rudkin AK, Lee AW, Aldrich E, Miller NR, Chen CS, Clin Exp Ophthalmol 2010 38 5 496 501 10.1111/j.1442-9071.2010.02280.x
16. Lipid metabolism disorders in patients with retinal artery occlusions. Fellinger C, Schmut O, Hofmann H, Klin Monbl Augenheilkd 1984 184 2 109 111 10.1055/s-2008-1054421 6716886
17. Digital subtraction carotid angiography and retinal arterial obstruction. Shah HG, Brown GC, Goldberg RE, Ophthalmology 1985 92 1 68 72 10.1016/S0161-6420(85)34075-7 3883282
18. Central retinal artery occlusion. Appen RE, Wray SH, Cogan DG, Am J Ophthalmol 1975 79 3 374 381 1121994
19. Berufsordnung für die Ärztinnen und Ärzte in Hessen. 1998 page 5, paragraph 15, http://www.laekh.de/upload/Rechtsquellen/berufsordnung.pdf
20. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1: EAGLE Study report no. 1. Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J, Maier-Lenz H, Schumacher M, Graefes Arch Clin Exp Ophthalmol 2006 244 8 950 956 10.1007/s00417-005-0140-2 16372192
21. Recovery following acute obstruction of the retinal and choroidal circulations. A case history. Duker JS, Brown GC, Retina 1988 8 4 257 260 10.1097/00006982-198808040-00007 3231917
22. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Mueller AJ, Neubauer AS, Schaller U, Kampik A, Arch Ophthalmol 2003 121 10 1377 1381 10.1001/archopht. 121.10.1377 14557172
23. Minimally invasive therapy for clinically complete central retinal artery occlusion-results and meta-analysis of literature. Neubauer AS, Mueller AJ, Schriever S, Gruterich M, Ulbig M, Kampik A, Klin Monbl Augenheilkd 2000 217 1 30 36 10.1055/s-2000-10380 10949814
24. Central retinal artery occlusion: visual outcome. Hayreh SS, Zimmerman MB, Am J Ophthalmol 2005 140 3 376 391 16138997
25. Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion. Ahn SJ, Kim JM, Hong JH, Woo SJ, Ahn J, Park KH, Han MK, Jung C, Invest Ophthalmol Vis Sci 2013 54 12 7746 7755 10.1167/iovs.13-12952 24176901
26. Circadian incidence of non-inflammatory retinal artery occlusions. Schmidt D, Schumacher M, Feltgen N, Graefes Arch Clin Exp Ophthalmol 2009 247 4 491 494 10.1007/s00417-008-0989-y 18989688
27. Systemic diseases in non-inflammatory branch and central retinal artery occlusion-an overview of 416 patients. Schmidt D, Hetzel A, Geibel-Zehender A, Schulte-Monting J, Eur J Med Res 2007 12 12 595 603 18024271
28. Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Wang JJ, Cugati S, Knudtson MD, Rochtchina E, Klein R, Klein BE, Wong TY, Mitchell P, Stroke 2006 37 7 1833 1836 10.1161/01.STR.0000226929.23297.75 16741179
29. Vascular risk factors for central retinal artery occlusion. Rudkin AK, Lee AW, Chen CS, Eye (Lond) 2010 24 4 678 681 10.1038/eye.2009.142 19521436